ESMO Breast Cancer 2026 Highlights: SERENA-6 - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

ESMO Breast Cancer 2026 Highlights: SERENA-6

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the SERENA-6 trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

Share

  • 1

    The SERENA-6 trial results were presented at the 2026 ESMO Breast Cancer Congress.

  • 2

    Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH, discussed the trial findings.

  • 3

    The trial focused on advancements in breast cancer treatment.

  • 4

    Details of the trial methodology and outcomes were highlighted.

  • 5

    The discussion emphasized the significance of the SERENA-6 findings in breast cancer research.

Original Source(s)

ESMO Breast Cancer 2026 Highlights: SERENA-6

  • June 26, 2026

Related Content

Outcomes for American Indian and Alaska Native Populations With Cancer in Traditional Medicare

2026 ASCO Breast Cancer Highlights: SENOMAC

Harold Burstein, MD, PhD, and Laura S. Dominici, MD, FACS, discuss highlights from the SENOMAC trial which sheds light on whether some patients with early breast cancer and limited lymph node involvement can safely avoid additional axillary surgery.

  • October 15, 2026

  • 1 min
Immunohistochemistry vs Molecular Breast Cancer Subtyping Among African Populations